Clinical Trials Browser

Phase 1/2 × Biliary Tract Neoplasms × binimetinib × Clear all

NCT02773459 2019-09-30

MEK162 in Combination With Capecitabine in Advanced Biliary Tract Cancer

Phase 1/2 Completed

Gastrointestinal

Biliary Tract Neoplasms